Objective: The purpose of this study is to elicit the amount of safety margin necessary around the ameloblastic lesion in view of preventing further recurrence. Materials and Methods: The study consisted of 25 cases of mandibular ameloblastoma. Diagnosis was based on clinical and radiological analysis and confirmed by histopathological report. An incisional biopsy was done preoperatively to confirm the diagnosis. Segmental resection was planned for all the cases. After the resection, postoperative panoramic radiograph of the specimen was taken followed by histopathological examination of its margin to detect tumor cell infiltration. Results and Conclusion: In all our cases, the ameloblastoma was infiltrating in nature. A follow-up period of 10 years showed neither recurrence nor implant failure. In our study, we conclude our safe margin for infiltrating variant of ameloblastoma based on histopathological report of the resected specimen.
A meloblastoma is a benign epithelial odontogenic tumor that often shows aggressive growth and high recurrence rate following conservative surgical treatment. [1] It is the most controversial tumor of the jaws because a greater diversity of opinion has existed concerning the clinical behavior, treatment, and malignant potential of this tumor than perhaps any other neoplasms found elsewhere in the body. The tumor has been aptly described by Robinson as a tumor that is usually "unicentric, nonfunctional, intermittent in growth, anatomically benign, and clinically persistent." [2] The growth characteristics of the tumor were classified into two major types: Expansive and invasive. The expansive type was defined as a tumor clearly demarcated from the surrounding fibrous connective tissues, with epithelium being flat or toothed shape. The invasive type was defined as one in which the epithelial islets of the tumor were infiltrated into the surrounding tissue in a cord-like, sporadic, or diffuse pattern, which plays an important role in the rate of recurrence following conservative surgical treatment. Ameloblastoma accounts for approximately 10% of all odontogenic tumors and 1% of the cysts of the jaws. [3] Several treatment modalities have been tried by various authors which include: [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] • Curettage • Enucleation • Chemical cauterization • Electro cauterization • En bloc excision • Radical resection • Radiotherapy/chemotherapy. "Evaluation of safety margin" in ameloblastoma of the mandible by surgical, radiological, and histopathological methods: An evidence-based study Secondary surgeries to eradicate recurrent tumors tend to be challenging and reconstruction is difficult because of the altered anatomy of the surgical site and tumor infiltration into the adjacent vital structures. [16] Hence, it becomes mandatory to take all the precautions during primary surgery to avoid recurrence by establishing a safe margin around the lesion. A suitable method of assessing this is through examining the periphery of the resected ameloblastoma specimens microscopically.
Materials and Methods
The reference literatures were retrieved from PubMed and ScienceDirect database. The search words used were ameloblastoma, recurrence rate of ameloblastoma, unicystic, multicystic, treatment modalities, and ameloblastoma of mandible. Further articles were retrieved using cross references in these literatures. About 25 cases (12 females and 13 males) with ameloblastoma involving the mandible reported were evaluated for safe margin. The ages of the patients range from 17 years to 58 years with an average of 37.5 years. Male to female ratio is approximately 1:1. Routine blood investigations were taken. All the patients were clinically examined. Panoramic radiograph was taken. Twenty-three of our patients showed multilocular radiolucent pattern and the other two patients had unilocular radiolucent pattern. An incisional biopsy was performed. On histopathological examination, biopsy specimen showed 12 cases as follicular ameloblastoma, 7 cases as plexiform ameloblastoma, 4 cases as acanthomatous ameloblastoma, and 2 cases as unicystic ameloblastoma. Radiographically, a safe margin of 1.5 cm was marked from the radiographic border of the lesion. Under general anesthesia, segmental resection of the mandible with a surgical clearance of 1.5 cm as planned with the preoperative panoramic radiograph was made. Patients were kept under antibiotic cover for 1 week, fed by Ryles tube for 10 days to avoid contamination. They were discharged after 10 days. After the resection, postoperative specimen margin was cut vertically into 2 pieces as 0.75 cm of equal thickness by a fret saw to detect tumor cell infiltration [ Figures 1 and 2] .
Results
From our study of resection and safe margin, we find that the multicystic variant of ameloblastoma is much more aggressive when compared with unicystic variant. In our case, the unicystic variant showed an infiltration rate up to 0.2 cm [ Figure 3 ]. The acanthomatous ameloblastoma showed 0.5 cm infiltration [ Figure 4 ] and follicular [ Figure 5 ] and plexiform variants showed 0.75 cm infiltration from the radiological margin [ Figure 6 ]. A regular monthly follow-up was made for a minimum period of 6 months to a maximum of 12 months followed by review of every 6 months for a period of 10 years. None of them showed clinical or radiological evidence of recurrence, but there is a possibility for the tumor cells to be present even beyond the radiological extent, especially for about 1 cm. Hence, a clearance of 1.5 cm on either side of the lesion during resection is thought to be advisable.
Discussion
Ever since the term "Adamantinoma" was coined by Mallassez in 1885, controversy has prevailed as to the most versatile form of treatment to prevent recurrence of the lesion. The origin of ameloblastoma is still controversial, but recently, the dental lamina has been accepted more than the enamel organ, epithelial rests, basal cells of the surface epithelium or epithelium of the odontogenic cysts as stated by Williams in 1993. [17] Until the study by Eversole et al., in 1984, ameloblastomas were classified according to the histological findings into follicular, plexiform, acanthomatous, granular cell, basal cell, squamous metaplastic, and other rare types. [18] In recent years, the literature has divided clinical ameloblastoma into unicystic, multicystic or solid, peripheral, and malignant subtypes. [1] Robinson on reviewing 293 cases reported an incidence of 83.7% in the mandible and 16.3% in the maxilla. [19, 20] In addition, Kameyama et al. in 1987 reported that there was a striking predilection for mandible with a mandible: Maxilla ratio of 23:1 in their clinico-pathological analysis containing 72 cases. [21] Riechart et al. in 1995 noted that mandible was affected over five times as frequently as the maxilla. [22] Sehdev et al. in 1974 analyzed 72 patients with ameloblastoma of mandible and they concluded that the conservative approach (curettage) led to 90% recurrence of mandibular ameloblastoma. Shatkin in 1965 and Sehdev in 1974 reported twenty cases of ameloblastoma and observed that 86% of the mandibular lesions recurred after curettage compared to a 14% recurrence rate after en bloc resection. [15, 23] Müller and Slootweg in 1985 found a 52% rate of recurrence in patients with primary ameloblastoma treated conservatively and a 25% rate of recurrence in patients with primary tumors treated by the radical approach. [24] Curi et al., 1997, in their study showed that the management of ameloblastoma with liquid nitrogen spray cryosurgery decreases the local recurrence rate. [25] Bradley reported several complications after cryosurgery therapy such as infection, sequestration, and pathologic fracture can appear because of a failure of adequate soft tissue cover. [4] In 1984, Atkinson et al. reported the use of mega voltage radiation for ten patients with recurrent ameloblastoma. Five of the six patients with mandibular tumor had a reduction in tumor size only. [1] There is a danger of postradiation sarcoma as reported by Becker and Pertl in 1967 and of osteoradionecrosis. [26] Small and Waldron in 1955 suggested that cauterization of the cavity after curettage is potentially more effective than curettage alone. [27] Muller and Slootweg (1985) and Curi in 1997 defined radical treatment as a procedure in which the intention was to remove the ameloblastoma with a margin of normal bone and any treatment that differed from this was defined as conservative. [24, 25] Although few authors suggest enucleation and curettage in Type I and Type II unicystic variants of ameloblastoma; in contrast, tumor cell invasion into the adjacent bone cannot be ruled out if there is a proliferation of ameloblastic cells lining the cystic lumen into the periphery of the connective tissue wall or if the island of ameloblastic cells were seen in the wall. The resected specimens of our cases consisted 1.5 cm of radiologically normal-appearing bone on either side of the lesion. The so-called normal bone part of the specimen which is 1.5 cm in thickness is divided into two halves measuring 0.75 cm each. Same division is done on the other side of the specimen also. The 0.75 cm slice of bone that was at the farthest part of the lesion revealed no invasion by the tumor tissue. Whereas the ten patients of follicular and plexiform variants show infiltration of 0.75 cm bone contained in the ameloblastoma cells. Hence, it is considered that 1 cm of clearance may not be adequate. In view of the recurrence-free concept of ameloblastoma resections, at least 1.5 cm of surgical clearance is essential.
Conclusion
From our study, we conclude that resection is the choice of treatment for infiltrating type of ameloblastoma. A preoperative biopsy is mandatory to find out the type of ameloblastoma. Based on the histological type of ameloblastoma, we suggest that radical resection with a safe margin of 1.5 cm followed by 
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